Microbiota-Derived Indole Metabolites Promote Human and Murine Intestinal Homeostasis through Regulation of Interleukin-10 Receptor

American Journal of Pathology

Volumn 188, Issue 5, 2018, Pages 1183-1194

  Alexeev, Erica E ^a   Lanis, Jordi M ^a   Kao, Daniel J ^a   Campbell, Eric L ^b   Kelly, Caleb J ^a   Battista, Kayla D ^a   Gerich, Mark E ^a   Jenkins, Brittany R ^c   Walk, Seth T ^c   Kominsky, Douglas J ^c   Colgan, Sean P ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; INDOLE; INDOLEPROPIONIC ACID; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR ALPHA; TRYPTOPHAN; DEXTRAN SULFATE; INDOLE DERIVATIVE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; DEPLETION; ESCHERICHIA COLI; FEMALE; GERMFREE MOUSE; HUMAN; HUMAN CELL; INTESTINAL HOMEOSTASIS; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE MUCOSA; INTESTINE PARAMETERS; MALE; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REMISSION; SIGNAL TRANSDUCTION; TRYPTOPHAN METABOLISM; ANIMAL; CELL LINE; CHEMICALLY INDUCED; DISEASE MODEL; HOMEOSTASIS; METABOLISM; MICROFLORA; PHYSIOLOGY;

ANIMALS; CELL LINE; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; HOMEOSTASIS; HUMANS; INDOLES; INTESTINAL MUCOSA; METABOLOMICS; MICE; MICROBIOTA; RECEPTORS, INTERLEUKIN-10;

EID: 85045053813     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2018.01.011     Document Type: Article

References (52)

1. Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., Diversity, stability and resilience of the human gut microbiota. Nature 489 (2012), 220–230.
2. Muniz, L.R., Knosp, C., Yeretssian, G., Intestinal antimicrobial peptides during homeostasis, infection, and disease. Front Immunol, 3, 2012, 310.
3. Xavier, R.J., Podolsky, D.K., Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007), 427–434.
4. Huttenhower, C., Kostic, A.D., Xavier, R.J., Inflammatory bowel disease as a model for translating the microbiome. Immunity 40 (2014), 843–854.
5. Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N., Pace, N.R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104 (2007), 13780–13785.
6. Engelhardt, K.R., Grimbacher, B., IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr Top Microbiol Immunol 380 (2014), 1–18.
7. Kominsky, D.J., Campbell, E.L., Ehrentraut, S.F., Wilson, K.E., Kelly, C.J., Glover, L.E., Collins, C.B., Bayless, A.J., Saeedi, B., Dobrinskikh, E., Bowers, B.E., MacManus, C.F., Muller, W., Colgan, S.P., Bruder, D., IFN-gamma-mediated induction of an apical IL-10 receptor on polarized intestinal epithelia. J Immunol 192 (2014), 1267–1276.
8. Colgan, S.P., Parkos, C.A., Matthews, J.B., D'Andrea, L., Awtrey, C.S., Lichtman, A., Delp, C., Madara, J.L., Interferon-γ induces a surface phenotype switch in intestinal epithelia: downregulation of ion transport and upregulation of immune accessory ligands. Am J Physiol 267:Pt 1 (1994), C402–C410.
9. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., Muller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993), 263–274.
10. Chaudhry, A., Samstein, R.M., Treuting, P., Liang, Y., Pils, M.C., Heinrich, J.M., Jack, R.S., Wunderlich, F.T., Bruning, J.C., Muller, W., Rudensky, A.Y., Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34 (2011), 566–578.
11. Wikoff, W.R., Anfora, A.T., Liu, J., Schultz, P.G., Lesley, S.A., Peters, E.C., Siuzdak, G., Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 106 (2009), 3698–3703.
12. Zelante, T., Iannitti, R.G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D'Angelo, C., Massi-Benedetti, C., Fallarino, F., Carvalho, A., Puccetti, P., Romani, L., Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2013), 372–385.
13. Hubbard, T.D., Murray, I.A., Bisson, W.H., Lahoti, T.S., Gowda, K., Amin, S.G., Patterson, A.D., Perdew, G.H., Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci Rep, 5, 2015, 12689.
14. Mascanfroni, I.D., Takenaka, M.C., Yeste, A., Patel, B., Wu, Y., Kenison, J.E., Siddiqui, S., Basso, A.S., Otterbein, L.E., Pardoll, D.M., Pan, F., Priel, A., Clish, C.B., Robson, S.C., Quintana, F.J., Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat Med 21 (2015), 638–646.
15. Kimura, A., Naka, T., Nohara, K., Fujii-Kuriyama, Y., Kishimoto, T., Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci U S A 105 (2008), 9721–9726.
16. Monteleone, I., Rizzo, A., Sarra, M., Sica, G., Sileri, P., Biancone, L., MacDonald, T.T., Pallone, F., Monteleone, G., Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 141 (2011), 237–248 248.e1.
17. Gaitanis, G., Magiatis, P., Stathopoulou, K., Bassukas, I.D., Alexopoulos, E.C., Velegraki, A., Skaltsounis, A.L., AhR ligands, malassezin, and indolo[3,2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis. J Invest Dermatol 128 (2008), 1620–1625.
18. Vlachos, C., Schulte, B.M., Magiatis, P., Adema, G.J., Gaitanis, G., Malassezia-derived indoles activate the aryl hydrocarbon receptor and inhibit Toll-like receptor-induced maturation in monocyte-derived dendritic cells. Br J Dermatol 167 (2012), 496–505.
19. McCracken, K.W., Howell, J.C., Wells, J.M., Spence, J.R., Generating human intestinal tissue from pluripotent stem cells in vitro. Nat Protoc 6 (2011), 1920–1928.
20. Pfaffl, M.W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 29, 2001, e45.
21. Albrecht, E., Waldenberger, M., Krumsiek, J., Evans, A.M., Jeratsch, U., Breier, M., Adamski, J., Koenig, W., Zeilinger, S., Fuchs, C., Klopp, N., Theis, F.J., Wichmann, H.E., Suhre, K., Illig, T., Strauch, K., Peters, A., Gieger, C., Kastenmuller, G., Doering, A., Meisinger, C., Metabolite profiling reveals new insights into the regulation of serum urate in humans. Metabolomics 10 (2014), 141–151.
22. Dieleman, L.A., Palmen, M.J., Akol, H., Bloemena, E., Pena, A.S., Meuwissen, S.G., Van Rees, E.P., Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114 (1998), 385–391.
23. Lanis, J.M., Alexeev, E.E., Curtis, V.F., Kitzenberg, D.A., Kao, D.J., Battista, K.D., Gerich, M.E., Glover, L.E., Kominsky, D.J., Colgan, S.P., Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia. Mucosal Immunol 10 (2017), 1133–1144.
24. Spence, J.R., Mayhew, C.N., Rankin, S.A., Kuhar, M.F., Vallance, J.E., Tolle, K., Hoskins, E.E., Kalinichenko, V.V., Wells, S.I., Zorn, A.M., Shroyer, N.F., Wells, J.M., Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470 (2011), 105–109.
25. Suzuki, A., Hanada, T., Mitsuyama, K., Yoshida, T., Kamizono, S., Hoshino, T., Kubo, M., Yamashita, A., Okabe, M., Takeda, K., Akira, S., Matsumoto, S., Toyonaga, A., Sata, M., Yoshimura, A., CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med 193 (2001), 471–481.
26. Hubbard, T.D., Murray, I.A., Perdew, G.H., Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation. Drug Metab Dispos 43 (2015), 1522–1535.
27. Lo, R., Matthews, J., High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq. Toxicol Sci 130 (2012), 349–361.
28. Mathieu, M.C., Lapierre, I., Brault, K., Raymond, M., Aromatic hydrocarbon receptor (AhR).AhR nuclear translocator- and p53-mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma cells. J Biol Chem 276 (2001), 4819–4827.
29. Lee, J.H., Wood, T.K., Lee, J., Roles of indole as an interspecies and interkingdom signaling molecule. Trends Microbiol 23 (2015), 707–718.
30. Manichanh, C., Borruel, N., Casellas, F., Guarner, F., The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9 (2012), 599–608.
31. Butto, L.F., Haller, D., Dysbiosis in intestinal inflammation: cause or consequence. Int J Med Microbiol 306 (2016), 302–309.
32. Sartor, R.B., Microbial influences in inflammatory bowel diseases. Gastroenterology 134 (2008), 577–594.
33. Kominsky, D.J., Keely, S., MacManus, C.F., Glover, L.E., Scully, M., Collins, C.B., Bowers, B.E., Campbell, E.L., Colgan, S.P., An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling. J Immunol 186 (2011), 6505–6514.
34. Newton, W.A., Snell, E.E., Catalytic properties of tryptophanase, a multifunctional pyridoxal phosphate enzyme. Proc Natl Acad Sci U S A 51 (1964), 382–389.
35. Hopkins, F.G., Cole, S.W., A contribution to the chemistry of proteids: part II. The constitution of tryptophane, and the action of bacteria upon it. J Physiol 29 (1903), 451–466.
36. Lee, J.H., Lee, J., Indole as an intercellular signal in microbial communities. FEMS Microbiol Rev 34 (2010), 426–444.
37. Martin, K., Morlin, G., Smith, A., Nordyke, A., Eisenstark, A., Golomb, M., The tryptophanase gene cluster of Haemophilus influenzae type b: evidence for horizontal gene transfer. J Bacteriol 180 (1998), 107–118.
38. De Preter, V., Machiels, K., Joossens, M., Arijs, I., Matthys, C., Vermeire, S., Rutgeerts, P., Verbeke, K., Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut 64 (2015), 447–458.
39. Wlodarska, M., Luo, C., Kolde, R., d'Hennezel, E., Annand, J.W., Heim, C.E., Krastel, P., Schmitt, E.K., Omar, A.S., Creasey, E.A., Garner, A.L., Mohammadi, S., O'Connell, D.J., Abubucker, S., Arthur, T.D., Franzosa, E.A., Huttenhower, C., Murphy, L.O., Haiser, H.J., Vlamakis, H., Porter, J.A., Xavier, R.J., Indoleacrylic acid produced by commensal peptostreptococcus species suppresses inflammation. Cell Host Microbe 22 (2017), 25–37.e6.
40. Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., Ferrante, M., Verhaegen, J., Rutgeerts, P., Vermeire, S., A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63 (2014), 1275–1283.
41. Eeckhaut, V., Machiels, K., Perrier, C., Romero, C., Maes, S., Flahou, B., Steppe, M., Haesebrouck, F., Sas, B., Ducatelle, R., Vermeire, S., Van Immerseel, F., Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 62 (2013), 1745–1752.
42. Sokol, H., Seksik, P., Furet, J.P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., Dore, J., Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15 (2009), 1183–1189.
43. Shimada, Y., Kinoshita, M., Harada, K., Mizutani, M., Masahata, K., Kayama, H., Takeda, K., Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLoS One, 8, 2013, e80604.
44. Venkatesh, M., Mukherjee, S., Wang, H., Li, H., Sun, K., Benechet, A.P., Qiu, Z., Maher, L., Redinbo, M.R., Phillips, R.S., Fleet, J.C., Kortagere, S., Mukherjee, P., Fasano, A., Le Ven, J., Nicholson, J.K., Dumas, M.E., Khanna, K.M., Mani, S., Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 41 (2014), 296–310.
45. Cheng, J., Shah, Y.M., Gonzalez, F.J., Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci 33 (2012), 323–330.
46. Devlin, A.S., Marcobal, A., Dodd, D., Nayfach, S., Plummer, N., Meyer, T., Pollard, K.S., Sonnenburg, J.L., Fischbach, M.A., Modulation of a circulating uremic solute via rational genetic manipulation of the gut microbiota. Cell Host Microbe 20 (2016), 709–715.
47. Heath-Pagliuso, S., Rogers, W.J., Tullis, K., Seidel, S.D., Cenijn, P.H., Brouwer, A., Denison, M.S., Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 37 (1998), 11508–11515.
48. Jin, U.H., Lee, S.O., Sridharan, G., Lee, K., Davidson, L.A., Jayaraman, A., Chapkin, R.S., Alaniz, R., Safe, S., Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities. Mol Pharmacol 85 (2014), 777–788.
49. Li, Y., Innocentin, S., Withers, D.R., Roberts, N.A., Gallagher, A.R., Grigorieva, E.F., Wilhelm, C., Veldhoen, M., Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147 (2011), 629–640.
50. Cervantes-Barragan, L., Chai, J.N., Tianero, M.D., Di Luccia, B., Ahern, P.P., Merriman, J., Cortez, V.S., Caparon, M.G., Donia, M.S., Gilfillan, S., Cella, M., Gordon, J.I., Hsieh, C.S., Colonna, M., Lactobacillus reuteri induces gut intraepithelial CD4+CD8alphaalpha+ T cells. Science 357 (2017), 806–810.
51. Bessede, A., Gargaro, M., Pallotta, M.T., Matino, D., Servillo, G., Brunacci, C., et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511 (2014), 184–190.
52. Belkaid, Y., Hand, T.W., Role of the microbiota in immunity and inflammation. Cell 157 (2014), 121–141.